CacheBy
ELK Biotechnology CBLB rabbit pAb
원본

ELK Biotechnology CBLB rabbit pAb

상품 한눈에 보기

CBLB 단백질을 인식하는 토끼 폴리클로날 항체로, WB 및 ELISA에 적합합니다. 인간, 생쥐, 랫트 시료에 반응하며 고순도 IgG 형태로 제공됩니다. 세포 내 단백질 유비퀴틴화 연구에 활용 가능합니다.

판매단위
pk
카탈로그 보기

카탈로그

2개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
ELK Biotechnology ES9621-100UL CBLB rabbit pAb, 100UL pk판매 단위 pk ·
재고 확인 필요
402,000원VAT 포함 442,200원
ELK Biotechnology ES9621-50UL CBLB rabbit pAb, 50UL pk판매 단위 pk ·
재고 확인 필요
301,000원VAT 포함 331,100원

ELK Biotechnology · ELK Biotechnology CBLB rabbit pAb

ELK Biotechnology CBLB rabbit pAb

제품 개요

CBLB 단백질을 검출하기 위한 토끼 유래 폴리클로날 항체입니다. 주로 Western Blot(WB) 및 ELISA 실험에 사용되며, 세포 내 단백질 유비퀴틴화 및 신호전달 경로 연구에 유용합니다.

제품 정보

항목 내용
Product name CBLB rabbit pAb
Applications WB; ELISA
Recommended Dilutions WB 1:500–2000, ELISA 1:5000–20000
Immunogen Synthesized peptide derived from part region of human protein
Species Reactivity Human; Rat; Mouse
Clonality Polyclonal
Isotype IgG
Concentration 1 mg/ml
Observed Band 108 kD
Gene ID (Human) 868
Human Swiss-Prot No Q13191
Cellular Localization Cytoplasm. Upon EGF stimulation, associates with endocytic vesicles.
Storage −20°C / 1 year

Background

The N-terminus of CBLB is composed of a phosphotyrosine binding (PTB) domain, linker region, and RING-type zinc finger. The PTB domain includes a four-helix bundle, calcium-binding EF hand, and divergent SH2 domain.
The RING-type zinc finger mediates binding to E2 ubiquitin-conjugating enzymes, while the UBA domain interacts with poly-ubiquitinated proteins.

CBLB acts as an E3 ubiquitin-protein ligase, transferring ubiquitin to substrates and promoting their proteasomal degradation. It negatively regulates TCR, BCR, and FCER1 signaling pathways. In naive T-cells, it inhibits VAV1 activation and requires CD28 costimulation for proliferation and IL-2 production.

In activated T-cells, CBLB inhibits PLCG1 activation and calcium mobilization, promoting anergy. In B-cells, it ubiquitinates SYK and promotes its degradation. It may also participate in EGFR ubiquitination and internalization.

Pathway: Protein modification; protein ubiquitination
Post-translational modifications (PTM): Auto-ubiquitinated upon EGF-mediated activation or CD28 costimulation; phosphorylated on tyrosine residues upon TCR or BCR activation.
Similarity: Contains CBL N-terminal domain, RING-type zinc finger, SH2 domain, UBA domain, and EF-hand-like domains.
Subunit interactions: Interacts with SH3 domain-containing proteins (LCK, CRK, SORBS1, LCP2, ZAP70, VAV1, FYN, FGR, PLCG1, GRB2, CRKL, PIK3R1, SH3KBP1/CIN85). Forms complexes with SH3KBP1/CIN85, CD2AP, and ARHGEF7.
Tissue specificity: Expressed in placenta, heart, lung, kidney, spleen, ovary, testis, fetal brain, and liver; absent in adult brain, liver, pancreas, salivary gland, and skeletal muscle. Present in lymphocytes at protein level.

ELK Biotechnology 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.